Potential Therapeutic Targets for Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinoma

被引:0
|
作者
Weiss, Vivian L.
Gonzalez, Raul S.
Shi, Chanjuan
机构
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
818
引用
收藏
页码:206A / 207A
页数:2
相关论文
共 50 条
  • [21] A Poorly Differentiated Esophageal Neuroendocrine Carcinoma With Brain Metastasis
    Swied, Muhammed Yaman
    Al Turk, Yahia
    Jegadeesan, Ramprasad
    ACG CASE REPORTS JOURNAL, 2023, 10 (09)
  • [22] Primary poorly differentiated neuroendocrine carcinoma of the oral cavity
    Huang, Danni
    Peng, Ying
    Xiong, Haofeng
    Hu, Xin
    Wang, Can
    Wang, Zijia
    Su, Tong
    Huang, Long
    ORAL DISEASES, 2022, 28 (07) : 1811 - 1815
  • [23] ASO Author Reflection: Postoperative Chemotherapy for Nonmetastatic, Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas
    Schmitz, Robin
    Moris, Dimitrios
    Strickler, John H.
    Blazer, Dan G., III
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (Suppl 3) : 804 - 805
  • [24] ASO Author Reflection: Postoperative Chemotherapy for Nonmetastatic, Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas
    Robin Schmitz
    Dimitrios Moris
    John H. Strickler
    Dan G. Blazer
    Annals of Surgical Oncology, 2020, 27 : 804 - 805
  • [25] Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: A systematic review
    Girardi, Daniel M.
    Silva, Andrea C. B.
    Rego, Juliana Florinda M.
    Coudry, Renata A.
    Riechelmann, Rachel P.
    CANCER TREATMENT REVIEWS, 2017, 56 : 28 - 35
  • [26] L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma
    Kaifi, Jussuf T.
    Zinnkann, Ulrich
    Yekebas, Emre F.
    Schurr, Paulus G.
    Reichelt, Uta
    Wachowiak, Robin
    Fiegel, Henning C.
    Petri, Susann
    Schachner, Melitta
    Izbicki, Jakob R.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (01) : 94 - 98
  • [27] L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma
    Jussuf T Kaifi
    Ulrich Zinnkann
    Emre F Yekebas
    Paulus G Schurr
    Uta Reichelt
    Robin Wachowiak
    Henning C Fiegel
    Susann Petri
    Melitta Schachner
    Jakob RIzbicki
    World Journal of Gastroenterology, 2006, (01) : 94 - 98
  • [28] Identification of critical pathways and potential therapeutic targets in poorly differentiated duodenal papilla adenocarcinoma
    Yuanxiang Lu
    Wensen Li
    Ge Liu
    Yongbo Yang
    Erwei Xiao
    Senmao Mu
    Yuqi Guo
    Deyu Li
    Guoyi Yan
    Cancer Cell International, 21
  • [29] Identification of critical pathways and potential therapeutic targets in poorly differentiated duodenal papilla adenocarcinoma
    Lu, Yuanxiang
    Li, Wensen
    Liu, Ge
    Yang, Yongbo
    Xiao, Erwei
    Mu, Senmao
    Guo, Yuqi
    Li, Deyu
    Yan, Guoyi
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [30] Utility of CT in differentiating liver metastases of well-differentiated gastroenteropancreatic neuroendocrine neoplasms from poorly-differentiated neuroendocrine neoplasms
    Yong Cui
    Xiaoting Li
    Shunyu Gao
    Zhongwu Li
    Yanling Li
    Ming Lu
    Yingshi Sun
    Chinese Journal of Cancer Research, 2018, 30 (01) : 31 - 39